Viewing StudyNCT02529878



Ignite Creation Date: 2024-05-06 @ 7:23 AM
Last Modification Date: 2024-10-26 @ 11:48 AM
Study NCT ID: NCT02529878
Status: UNKNOWN
Last Update Posted: 2016-07-26
First Post: 2015-08-19

Brief Title: Study of Convernsion Therapy Using S1Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer
Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University
Organization: The First Affiliated Hospital of Zhejiang Chinese Medical University

Organization Data

Organization: The First Affiliated Hospital of Zhejiang Chinese Medical University
Class: OTHER
Study ID: ECGC-0001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Jiangsu HengRui Medicine Co Ltd INDUSTRY